Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Oesophagogastric Cancer × Cisplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 77 Nasopharyngeal Carcinoma 52 Uterine Cervical Neoplasms 39 Lung Neoplasms 39 Head and Neck Neoplasms 28 Esophageal Neoplasms 25 Esophageal Squamous Cell Carcinoma 24 Squamous Cell Carcinoma of Head and Neck 20 Stomach Neoplasms 15 Small Cell Lung Carcinoma 15 Breast Neoplasms 14 Recurrence 11 Ovarian Neoplasms 10 Nasopharyngeal Neoplasms 10 Carcinoma, Squamous Cell 10 Neoplasm Metastasis 9 Lymphoma, Large B-Cell, Diffuse 8 Central Nervous System Neoplasms 8 Neuroblastoma 7 Lymphoma 7 Hypopharyngeal Neoplasms 7 Pancreatic Neoplasms 6 Oropharyngeal Neoplasms 6 Neoplasms 6 Triple Negative Breast Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Follicular 5 Biliary Tract Neoplasms 5 Urinary Bladder Neoplasms 4

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡